Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREnd: Palbociclib Monotherapy vs Combination in Advanced Breast Cancer
NCT02549430Phase 2Completed
- Sponsor
- Fondazione Sandro Pitigliani
- Start
- Oct 2012
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by Fondazione Sandro Pitigliani. Started Oct 2012; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02549430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549430.